Back to
Belvedere Trading LLC
CORT2 quarters
Position history for
Belvedere Trading LLC's holdings in Corcept Therapeutics Incorporated.
No. Belvedere Trading exited its CORT (Corcept Therapeutics) position in Q2 2022. Its Q1 2022 13F listed 12,624 shares worth $293,000. Belvedere Trading first reported CORT in Q1 2022 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$293,000
Total Shares Change
-12,624
Quarter-by-Quarter History
Other major holders of CORT: BlackRock, Inc., VANGUARD GROUP INC